What is the primary use of corticosteroids in respiratory therapy?

Corticosteroids are primarily used in respiratory therapy to reduce airway inflammation. This is crucial in managing conditions like asthma, chronic obstructive pulmonary disease (COPD), and other respiratory disorders where inflammation plays a significant role in airway constriction and obstruction. By decreasing inflammation, corticosteroids help to open up the airways, making it easier for patients to breathe. This reduction in inflammation can lead to fewer exacerbations, improved lung function, and an overall decrease in symptoms associated with respiratory conditions.

For instance, in asthma management, inhaled corticosteroids are often the first-line treatment because they target the underlying inflammatory process, providing long-term control of the disease. This intervention can prevent the need for oral steroids, which are associated with more systemic side effects.

Understanding the role of corticosteroids in managing inflammation is crucial for their effective use in respiratory therapy, emphasizing their importance in improving patient outcomes in respiratory illnesses.